Assay performance and the Z’-factor in HTS

Research output: Contribution to specialist publicationArticle


High-throughput screening (HTS) is a common method of drug discovery, wherein a large library (sometimes containing more than a million compounds) is screened using an in vitro or phenotypic assay. The assay is used to identify an active compound that brings about the desired change (known as a ‘hit’) from many inactive compounds, and hence assay quality is critical. Hit identification is strongly dependent on the difference in behaviour between active and inactive compounds (the ‘signal window’), and the variation within the data (as measured by the standard deviations). Intuitively, it will be easier to identify a hit when there is a large signal window and low variability.
Original languageEnglish
Number of pages3
Specialist publicationDrug Target Review
PublisherRussell Publishing Ltd
Publication statusPublished - 30 Mar 2023


Dive into the research topics of 'Assay performance and the Z’-factor in HTS'. Together they form a unique fingerprint.

Cite this